{
  "id": "5156beb4d24251bc05000089",
  "type": "yesno",
  "question": "Can Alzheimer's disease related miRNAs be detected in patients' blood?",
  "ideal_answer": "Yes. It has been demonstrated that blood miRNAs could be useful as biomarkers in Alzheimer's disease.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23030236",
    "http://www.ncbi.nlm.nih.gov/pubmed/23054683",
    "http://www.ncbi.nlm.nih.gov/pubmed/21548758",
    "http://www.ncbi.nlm.nih.gov/pubmed/22155483",
    "http://www.ncbi.nlm.nih.gov/pubmed/23435408",
    "http://www.ncbi.nlm.nih.gov/pubmed/23528227",
    "http://www.ncbi.nlm.nih.gov/pubmed/21709374",
    "http://www.ncbi.nlm.nih.gov/pubmed/19936094"
  ],
  "snippets": [
    {
      "text": "miRNAs are aberrantly expressed in AD, and these have been implicated in the regulation of amyloid-\u03b2 (A\u03b2) peptide, tau, inflammation, cell death, and other aspects which are the main pathomechanisms of AD. In addition, regulation of miRNAs varies in blood, and cerebral spinal fluid may indicate alterations in AD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23054683",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "miRNA microarray analysis was carried out on blood of rats at 1 week and 2 months after injection. RESULTS: Many up- and downregulated miRNAs were detected.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23030236",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Blood miRNAs could be useful as biomarkers for exposure to nanoparticles. miR-298 regulates \u03b2-amyloid (A\u03b2) precursor protein-converting enzyme-1 (BACE1) in Alzheimer's disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23030236",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": " We previously studied microRNAs (miRNAs) in AD autopsy brain samples and reported a connection between miR-137, -181c, -9, -29a/b and AD, through the regulation of ceramides. In this study, the potential role of these miRNAs as diagnostic markers for AD was investigated. We identified that these miRNAs were down-regulated in the blood serum of probable AD patients. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22155483",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "287 with Alzheimer disease (AD) as compared with 344 age- and gender-matched controls. In addition, we evaluated expression levels of hnRNP-A1 and its regulatory microRNA (miR)-590-3p in blood cells from patients and controls.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21548758",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Decreased relative expression levels of hsa-miR-590-3p was observed in patients with AD versus controls (0.685\u2009\u00b1\u20090.080 versus 0.931\u2009\u00b1\u20090.111, p\u2009=\u20090.079), and correlated negatively with hnRNP-A1 mRNA levels (r\u2009=\u2009-0.615, p\u2009=\u20090.0237).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21548758",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "expression analysis of Sp1 and its regulatory microRNAs (hsa-miR-29b and hsa-miR-375) has been performed in peripheral blood mononuclear cells (PBMCs), together with Sp1 protein analysis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23435408",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Significantly decreased relative expression levels of hsa-miR-29b, but not of hsa-miR-375, were observed in AD patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23435408",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Sp1 and its regulatory hsa-miR-29b are deregulated in AD patients, possibly leading to aberrant production of downstream target genes involved in the pathogenesis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23435408",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We previously observed that miR-137, -181c, -9, and 29a/b post-transcriptionally regulate SPT levels, and the corresponding miRNA levels in the blood sera are potential diagnostic biomarkers for AD. Here, we observe a negative correlation between cortical A\u03b242 and sera A\u03b242, and a positive correlation between cortical miRNA levels and sera miRNA levels suggesting their potential as noninvasive diagnostic biomarkers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23528227",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D035683",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001773",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=diseases_category",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001798",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016229",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D023582",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000544"
  ],
  "exact_answer": "Yes"
}